Levy, Benjamin P <br/><br/>
Attacking a Moving Target: Understanding Resistance and Managing Progression in EGFR-Positive Lung Cancer Patients Treated With Tyrosine Kinase Inhibitors.  [electronic resource] 

 -  Oncology (Williston Park, N.Y.)  Jul 2016 
 - 601-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0890-9091 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers, Tumor--genetics<br/>Disease Progression<br/>Drug Resistance, Neoplasm--drug effects<br/>ErbB Receptors--genetics<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Mutation<br/>Neoplasm Staging<br/>Protein Kinase Inhibitors--therapeutic use<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Quality of Life<br/>Randomized Controlled Trials as Topic<br/>Treatment Outcome